FDA Inspection
The Ritedose CorporationThe Ritedose Corporation – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns The Ritedose Corporation, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a5ca351d-8c5a-491e-9500-e6796c673502
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015894
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 820.100(b)Documentation
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 820.20(c)Management review - Lack of or inadequate procedures
- 21 CFR 820.30(j)Design history file
- 21 CFR 820.20(b)Lack of or inadequate organizational structure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Ritedose Corporation
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2025 | VAI | Atlanta District Office | Drug Quality Assurance |
| March 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 16, 2018 | Not classified | Atlanta District Office | |
| July 31, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Ritedose Corporation
- FDA Inspection 1250871 - 2025-02-28
- FDA Inspection 1165123 - 2022-03-22
- FDA Inspection 1089541 - 2019-04-18
- FDA Inspection 1045279 - 2018-02-16
- FDA Inspection 940802 - 2015-07-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.